InvestorsHub Logo
Followers 14
Posts 1732
Boards Moderated 0
Alias Born 04/07/2014

Re: DewmBoom post# 145351

Tuesday, 07/10/2018 3:54:53 AM

Tuesday, July 10, 2018 3:54:53 AM

Post# of 330165
First of all, you will have to define a "True Long" for me. Secondly, of course, an extensive advertisement campaign is very costly, but that can be underwritten by an outside financial source. With a product like Actipatch (i.e., monster in your pocket product), you can't tell me that BIEL can't find an investment source willing to foot the bill for an AD campaign. I don't think the campaign needs to be world class, if you know what I mean. Also, we are told that BIEL has partners all over the world and what's curious, to my knowledge, not one of them is advertising Actipatch on a serious scale. What! Why? At this juncture in healthcare history, in particular, the issue with the pain medication crisis, Actipatch appears to be a God-sent. So, why BIEL isn't screaming this at the top of their voice, as loudly as possible? Well, that's the salient question! Furthermore, regarding the FDA being a stick-in-the-mud when it come to issuing clearance for BIEL, well, a little bit advertisement would go a long way to put pressure on the FDA to move in BIEL's favor. With the public having knowledge of a strong (do no harm) alternative to pain medications, the FDA would be forced to get off its butt and do the right thing; thus, issue a full clearance for Actipatch. That's My Take!

GLTA!!!

P.S. I agree, we will most surely get there, but what's currently going on is quite strange.

Logic Rules!